Two studies and an editorial published yesterday in the Journal of the American Medical Association (JAMA), provide compelling evidence which researchers indicate may warrant an Avandia recall. One study confirmed earlier findings that Avandia increases the risk of heart attacks, while a second study found that Actos, an alternative drug… Read more.
The FDA announced late yesterday that the manufacturers of Avandia and Actos have agreed to add a stronger black box warning regarding the increased risk of heart failure. The announcement comes two months after federal regulators testified at a congressional hearing that they would be requesting the drug makers add… Read more.
Monday an FDA advisory panel reviewed whether there should be an Avandia recall, but recommended that the type 2 diabetes drug remain on the market with stronger warnings regarding the heart risks. Although the panel voted 20 to 3 that Avandia does increase the risk of heart attacks, they did… Read more.
The FDA will hold advisory panel meetings next week to review whether there should be an Avandia recall following reports which indicate users of the diabetes drug face a 43% increased risk of heart attacks. Although the FDA is not required to follow the advise of their advisory panels, they… Read more.
Concerned about the possible increased risk of heart attacks and death recently associated with Avandia, users may find useful information in two reports which compare Avandia with Actos and other diabetes medications. One report indicates that Actos may not carry the same heart attack risk as Avandia, and the other… Read more.
According to the Associated Press, the number of reported heart problems associated with Avandia has jumped significantly since a study published May 21 in the New England Journal of Medicine demonstrated an increased risk of heart attacks and death associated with the diabetes drug. With knowledge of the increased risk,… Read more.
Yesterday at the annual meeting of the American Diabetes Association in Chicago, the debate about heart risks associated with Avandia was a main topic. Concerns have been widespread among diabetes patients and doctors about an increased risk of heart attacks and heart related death since a study was published last… Read more.
Last month, a study was published in the New England Journal of Medicine after independent researchers reviewed data from clinical trials which showed that Avandia side effects could increase the risk of heart attacks and cardiovascular death. The only reason those independent researchers had access to that data was because… Read more.
An Avandia class action suit has been filed against GlaxoSmithKline, PLC, the maker of the Type 2 diabetes medication. The lawsuit was filed by shareholders who claim that they were misled by the company about the increased risk of heart attacks and heart related death, which has recently been linked… Read more.
During congressional hearings on Wednesday, FDA officials indicated that they intend to ask drug makers to add a new ‘black box’ warning to Avandia and Actos. The warning will highlight the increased risk of heart failure associated with the two drugs which are used to treat Type 2 diabetes. The… Read more.
